You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

3bnc117

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in United States (Albuvirtide, 3BNC117, Baseline ART)

Recruiting
  • HIV-1-infection
  • Palm Springs, California
  • +6 more
Sep 28, 2021

Human Immunodeficiency Virus Trial in Boston, New York (3BNC117, 10-1074, Analytical treatment interruption)

Completed
  • Human Immunodeficiency Virus
  • 3BNC117
  • +2 more
  • Boston, Massachusetts
  • +1 more
Feb 11, 2022

HIV/AIDS Trial in Beijing (Albuvirtide, 3BNC117)

Not yet recruiting
  • HIV/AIDS
  • Beijing, China
    Peking Union Medical College Hospital
Mar 24, 2021

Hiv Trial in Denmark, United Kingdom (Romidepsin, 3BNC117, Antiretrovirals)

Active, not recruiting
  • Hiv
  • Aalborg, Denmark
  • +6 more
Sep 3, 2021

Human Immunodeficiency Virus (HIV) Trial in New York, Aarhus, Cologne (3BNC117, Romidepsin)

Completed
  • Human Immunodeficiency Virus (HIV)
  • New York, New York
  • +2 more
Feb 3, 2021

HIV-1 Infection Trial in New York (3BNC117, ART Interruption)

Completed
Has Results
  • HIV-1 Infection
  • 3BNC117
  • ART Interruption
  • New York, New York
    The Rockefeller University
Jul 8, 2020

Human Immunodeficiency Virus (HIV) Trial in New York, Cologne (3BNC117, 10-1074, Analytical treatment interruption)

Completed
  • Human Immunodeficiency Virus (HIV)
  • 3BNC117
  • +3 more
  • New York, New York
  • +1 more
Aug 20, 2018

Human Immunodeficiency Virus Trial in New York (3BNC117, 10-1074, Placebo)

Completed
  • Human Immunodeficiency Virus
  • 3BNC117
  • +2 more
  • New York, New York
    The Rockefeller University
Apr 13, 2018